|
RERE expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.6881999998517E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.537500E-03 |
| Normal-vs-Stage2 |
1.84559999999445E-05 |
| Normal-vs-Stage3 |
4.91370000021973E-07 |
| Normal-vs-Stage4 |
5.07990000064851E-08 |
| Stage1-vs-Stage2 |
1.150120E-02 |
| Stage1-vs-Stage3 |
1.028020E-02 |
| Stage1-vs-Stage4 |
5.969400E-04 |
| Stage2-vs-Stage3 |
5.195600E-01 |
| Stage2-vs-Stage4 |
7.096600E-01 |
| Stage3-vs-Stage4 |
2.340600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.33650000014407E-07 |
| Normal-vs-AfricanAmerican |
3.759700E-03 |
| Normal-vs-Asian |
7.635600E-01 |
| Caucasian-vs-AfricanAmerican |
9.076000E-01 |
| Caucasian-vs-Asian |
9.451500E-02 |
| AfricanAmerican-vs-Asian |
1.501770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.59040000058397E-08 |
| Normal-vs-Female |
3.080700E-03 |
| Male-vs-Female |
4.796200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.961700E-03 |
| Normal-vs-Age(41-60Yrs) |
4.781900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.25889999980089E-07 |
| Normal-vs-Age(81-100Yrs) |
9.798200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.107800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.983200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.997600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.896200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.049900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.025000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.242100E-02 |
| Normal-vs-Grade 2 |
1.011910E-02 |
| Normal-vs-Grade 3 |
1.53059998009297E-09 |
| Normal-vs-Grade 4 |
3.83300002848586E-09 |
| Grade 1-vs-Grade 2 |
4.944800E-03 |
| Grade 1-vs-Grade 3 |
2.14610000004445E-06 |
| Grade 1-vs-Grade 4 |
1.3751999999867E-06 |
| Grade 2-vs-Grade 3 |
5.74409999999359E-05 |
| Grade 2-vs-Grade 4 |
6.05040000000168E-05 |
| Grade 3-vs-Grade 4 |
1.921590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.163440E-01 |
| Normal-vs-ccB subtype |
2.22510010416954E-10 |
| ccA subtype-vs-ccB subtype |
7.05820002444568E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.80339999997526E-07 |
| Normal-vs-N1 |
1.600420E-03 |
| N0-vs-N1 |
5.796800E-01 |
|
|
